Arcturus Therapeutics Holdings Inc.

NASDAQ:ARCT

Biotechnology

Healthcare
$8.04 +1.97%

+$0.15 today

Market cap
$231.73M
Beta
2.35
P/E (TTM)
-2.7
EPS (TTM)
-$2.77
52W Low $5.85High $24.17

Volume 0.64M

Average 0.43M

Balance Sheet

Inspect the capital base behind the business.

Assets

$271.15M

FY 2025 · Annual

-21.2% YoY

Liabilities

$57.16M

FY 2025 · Annual

-44.6% YoY

Equity

$213.99M

FY 2025 · Annual

-11.2% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents370.49M391.88M292.01M237.03M230.91M
Short-term Investments00000
Net Receivables3.37M2.76M32.06M3.97M5.56M
Inventory00000
Other Current Assets08.69M55M64.98M4.97M
Total Current Assets378.96M403.33M386.59M305.98M241.45M
Property, Plant & Equipment (Net)11.26M44.96M40.93M36.21M27.82M
Goodwill00000
Intangible Assets00000
Long-term Investments515K01.89M01.89M
Tax Assets00000
Other Non-current Assets2.08M2.09M01.89M0
Total Non-current Assets13.85M47.05M42.81M38.09M29.7M
Total Assets392.81M450.39M429.4M344.07M271.15M
Account Payables10.06M7.45M5.28M7.19M4.24M
Short-term Debt22.47M60.66M000
Tax Payables01.3M641K00
Deferred Revenue43.48M36.12M47.34M21.94M8.25M
Other Current Liabilities3.58M4.04M18.5M13.31M6.95M
Total Current Liabilities99.54M126.98M81.99M65.49M36.38M
Long-term Debt40.63M0000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)020.07M42.5M12.6M0
Other Non-current Liabilities19.93M2.8M497K00
Total Non-current Liabilities65.07M53.09M68.9M37.6M20.78M
Total Liabilities164.6M180.08M150.89M103.09M57.16M
Common Stock26K27K27K27K28K
Retained Earnings(347.49M)(338.14M)(367.87M)(448.81M)(514.59M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity228.21M270.31M278.51M240.98M213.99M
Total Debt69.15M94.76M30.22M28.55M25M
Net Debt(301.35M)(297.13M)(261.79M)(208.48M)(205.91M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$211.4M
Receivables$1.3M
Other Current$4.2M
Total Current Assets$216.9M
PP&E (Net)$26.5M
Other Non-current$2.0M
Total Non-current Assets$28.5M
Total Assets$245.4M

Analysis

Selected assets total $245.4M for Latest. The largest visible component is Cash & Equivalents at $211.4M, about 86.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
SC 13G/ASC 13G/A filingOct 29, 2026
SC 13G/ASC 13G/A filingOct 7, 2026

How much cash does ARCT have?

Arcturus Therapeutics Holdings Inc. (ARCT) reported $230.91M in cash and equivalents in fiscal 2025.

How much debt does ARCT carry?

Arcturus Therapeutics Holdings Inc. (ARCT) reported $25.00M of total debt, with net debt of -$205.91M.